Adiponectin receptor 1 gene (ADIPOR1) variant is associated with advanced age-related macular degeneration in Finnish population

Neuroscience Letters

Volumn 513, Issue 2, 2012, Pages 233-237

  Kaarniranta, Kai ^a,c   Paananen, Jussi ^a   Nevalainen, Tanja ^b   Sorri, Iiris ^c   Seitsonen, Sanna ^d   Immonen, Ilkka ^d   Salminen, Antero ^a,c   Pulkkinen, Leena ^a   Uusitupa, Matti ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adiponectin; Aging; Macular degeneration; Polymorphism

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHIBITION KINETICS; INTRON; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PIGMENT EPITHELIUM; POPULATION GENETICS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FINLAND; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN;

EID: 84858998038     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.050     Document Type: Article

References (47)

1. Age-Related Eye Disease Study Research Group Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-Related Eye Disease Study Report Number 3. Ophthalmology 2000, 107:2224-2232.
2. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Blasiak J., Szaflik J., Szaflik J.P. Implications of altered iron homeostasis for age-related macular degeneration. Front. Biosci. 2011, 16:1551-1559.
5. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 2003, 278:45021-45026.
6. Choi J.K., Lym Y.L., Moon J.W., Shin H.J., Cho B. Diabètes mellitus and early age-related macular degeneration. Arch. Ophthalmol. 2011, 129:196-199.
7. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) report no. 19. Ophthalmology 2005, 112:533-539. Age-Related Eye Disease Study Research Group.
8. Cnop M., Havel P.J., Utzchhneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetelogia 2003, 46:459-469.
9. Damcott C.M., Ott S.H., Pollin T.I., Reinhart L.J., Wang J., O'connell J.R., Mitchell B.D., Shuldiner A.R. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 2005, 54:2245-2250.
10. Delcourt C., Michel F., Colvez A., Lacroux A., Delage M., Vernet M.H. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001, 8:237-249. POLA Study Group.
11. Hirvelä H., Luukinen H., Läärä E., Sc L., Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996, 103:871-877.
12. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
13. Jung C.H., Ro S-H., Cao J., Otto N.M. D-H Kim, mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
14. Kaarniranta K., Hyttinen J.M.T., Ryhänen T., Viiri J., Paimela T., Toropainen E., Sorri I., Salminen A. Mechanisms of protein aggregation in the retinal pigment epithelial cells. Front. Biosci. (Elite Ed.) 2010, 2:1374-1384.
15. Kaarniranta K., Salminen A. Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors. J. Mol. Med. 2009, 87:117-123.
16. Kaarniranta K., Salminen A., Eskelinen E.L., Kopitz J. Heat shock proteins as gatekeepers of proteolytic pathways-implications for age-related macular degeneration (AMD). Ageing Res. Rev. 2009, 8:128-139.
17. Kaarniranta K., Salminen A., Haapasalo A., Soininen H., Hiltunen M. Age-related macular degeneration (AMD): Alzheimer's Disease in the Eye?. J. Alzheimers Dis. 2011, 24:615-631.
18. Kantartzis K., Fritsche A., Machicao F., Häring H.U., Stefan N. The -8503 G/A polymorphism of the adiponectin receptor 1 gene is associated with insulin sensitivity dependent on adiposity. Diabetes Care 2006, 29:464.
19. Klein R., Klein B.E., Jensen S.C. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997, 104:1804-1812.
20. Klein R., Klein B.E., Tomany S.C., Cruickshanks K.J. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003, 110:1273-1280.
21. Klein R., Meuer S.M., Knudtson M.D., Iyengar S.K., Klein B.E. The epidemiology of retinal reticular drusen. Am. J. Ophthalmol. 2008, 145:317-326.
22. Lau W.B., Tao L., Wang Y., Li R., Ma X.L. Systemic adiponectin malfunction as a risk factor for cardiovascular disease. Antioxid. Redox Signal. 2011, 15:1863-1873.
23. van Leeuwen R., Ikram M.K., Vingerling J.R., Witteman J.C.M., Hofman A., de Jong P.T. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam study Invest. Ophthalmol. Vis. Sci. 2003, 44:3771-3777.
24. Menzaghi C., Trischitta V., Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56:1198-1209.
25. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
26. Paunksnis A., Cimbalas A., Cerniauskiene L.R., Luksiene D.I., Margeviciene L., Domarkiene S., Tamosiunas A., Norkus A. Early age-related maculopathy and risk factors of cardiovascular disease in middle-aged Lithuanian urban population. Eur. J. Ophthalmol. 2005, 15:255-262.
27. Peeters A., Magliano D.J., Stevens J., Duncan B.B., Klein R., Wong T.Y. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch. Ophthalmol. 2008, 126:1554-1560.
28. Pruim R.J., Welch R.P., Sanna S., Teslovich T.M., Chines P.S., Boehnke T.P.M., Abecasis G.R., Willer C.J. LocusZoom: regional visualization of gnome-wide association scan results. Bioinformatics 2010, 26:2336-2337.
29. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., Sham P.C. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 2007, 81:559-575.
30. Ryhänen T., Hyttinen J.M.T., Kopitz J., Rilla K., Kuusisto E., Mannermaa E., Viiri J., Holmberg C.I., Immonen I., Meri S., Parkkinen J., Eskelinen E.L., Uusitalo H., Salminen A., Kaarniranta K. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell. Mol. Med. 2009, 13:3616-3631.
31. Salminen A., Kaarniranta K. Regulation of the aging process in autophagy. Trends Mol. Med. 2009, 15:217-224.
32. Schaumberg D.A., Christen W.G., Hankinson S.E., Glyn R.J. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch. Ophthalmol. 2001, 119:1259-1265.
33. Seddon J.M., Cote J., Davis N., Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch. Ophthalmol. 2003, 121:785-792.
34. Shibata R., Ouchi N., Kihara S., Sato K., Funahashi T., Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 2004, 279:28670-28674.
35. Siitonen N., Pulkkinen L., Lindström J., Kolehmainen M., Eriksson J.G., Venojärvi M., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Tuomilehto J., Uusitupa M. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med. Genet. 2011, 12:5.
36. Siitonen N., Pulkkinen L., Mager U., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Tuomilehto J., Laakso M., Uusitupa M. Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 2006, 49:1795-1805.
37. Smith W., Mitchell P., Leeder S.R., Wang J.J. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol. 1998, 116:583-587.
38. Stefan N., Machicao F., Staiger H., Machann J., Schick F., Tschritter O., Spieth C., Weigert C., Fritsche A., Stumvoll M., Häring H.U. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 2005, 48:2282-2291.
39. Swarbrick M.M., Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab. Syndr. Relat. Disord. 2008, 6:87-102.
40. Tolppanen A.M., Nevalainen T., Kolehmainen M., Seitsonen S., Immonen I., Uusitupa M., Kaarniranta K., Pulkkinen L. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol. Vis. 2009, 15:762-770.
41. Topouzis F., Anastasopoulos E., Augood C., Bentham G.C., Chakravarthy U., de Jong P.T., Rahu M., Seland J., Soubrane G., Tomazzoli L., Vingerling J.R., Vioque J., Young I.S., Fletcher A.E. Association of diabetes with age-related macular degeneration in the EUREYE study. Br. J. Ophthalmol. 2009, 93:1037-1041.
42. Viiri J., Hyttinen J.M., Ryhänen T., Rilla K., Paimela T., Kuusisto E., Siitonen A., Urtti A., Salminen A., Kaarniranta K. p62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol. Vis. 2010, 16:1399-1414.
43. Vingerling J.R., Dielemans I., Bots M.L., Hofman A., Grobbee D.E., de Jong P.T. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol. 1995, 142:404-409.
44. Wang A.L., Lukas T.J., Yuan M., Du N., Tso M.O., Neufeld A.H. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One 2009, 4:e4160.
45. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
46. Yu Z., Han S., Cao X., Zhu C., Wang X., Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 2011, 10.1038/oby.2011.148.
47. Ziemke F., Mantzoro C.S. Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 2010, 91:258-261.